Literature DB >> 36068478

Genetic Ancestry Inference for Pharmacogenomics.

I King Jordan1, Shivam Sharma2, Shashwat Deepali Nagar3, Augusto Valderrama-Aguirre4, Leonardo Mariño-Ramírez5.   

Abstract

Genetic ancestry inference can be used to stratify patient cohorts and to model pharmacogenomic variation within and between populations. We provide a detailed guide to genetic ancestry inference using genome-wide genetic variant datasets, with an emphasis on two widely used techniques: principal components analysis (PCA) and ADMIXTURE analysis. PCA can be used for patient stratification and categorical ancestry inference, whereas ADMIXTURE is used to characterize genetic ancestry as a continuous variable. Visualization methods are critical for the interpretation of genetic ancestry inference methods, and we provide instructions for how the results of PCA and ADMIXTURE can be effectively visualized.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Admixture; Genetic ancestry inference; Genetic variants; Health disparities; Pharmacogenomics; Population-specific drug efficacy

Mesh:

Year:  2022        PMID: 36068478      PMCID: PMC9486757          DOI: 10.1007/978-1-0716-2573-6_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

Review 2.  Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.

Authors:  Mei-Ling Chen
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies.

Authors:  S U Yasuda; L Zhang; S-M Huang
Journal:  Clin Pharmacol Ther       Date:  2008-07-09       Impact factor: 6.875

Review 4.  Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice.

Authors:  S-M Huang; R Temple
Journal:  Clin Pharmacol Ther       Date:  2008-09       Impact factor: 6.875

Review 5.  A review and assessment of potential sources of ethnic differences in drug responsiveness.

Authors:  Thorir D Bjornsson; John A Wagner; Stephen R Donahue; Dawn Harper; Aziz Karim; Marlene S Khouri; William R Murphy; Kristin Roman; Dennis Schneck; Daryl S Sonnichsen; Dennis J Stalker; Stephen D Wise; Stuart Dombey; Caroline Loew
Journal:  J Clin Pharmacol       Date:  2003-09       Impact factor: 3.126

Review 6.  Racial/ethnic differences in drug disposition and response: review of recently approved drugs.

Authors:  A Ramamoorthy; M A Pacanowski; J Bull; L Zhang
Journal:  Clin Pharmacol Ther       Date:  2015-01-20       Impact factor: 6.875

7.  SCIENCE AND SOCIETY. Taking race out of human genetics.

Authors:  Michael Yudell; Dorothy Roberts; Rob DeSalle; Sarah Tishkoff
Journal:  Science       Date:  2016-02-05       Impact factor: 47.728

8.  Race and Genetic Ancestry in Medicine - A Time for Reckoning with Racism.

Authors:  Luisa N Borrell; Jennifer R Elhawary; Elena Fuentes-Afflick; Jonathan Witonsky; Nirav Bhakta; Alan H B Wu; Kirsten Bibbins-Domingo; José R Rodríguez-Santana; Michael A Lenoir; James R Gavin; Rick A Kittles; Noah A Zaitlen; David S Wilkes; Neil R Powe; Elad Ziv; Esteban G Burchard
Journal:  N Engl J Med       Date:  2021-01-06       Impact factor: 91.245

9.  Population Pharmacogenomics for Precision Public Health in Colombia.

Authors:  Shashwat Deepali Nagar; A Melissa Moreno; Emily T Norris; Lavanya Rishishwar; Andrew B Conley; Kelly L O'Neal; Sara Vélez-Gómez; Camila Montes-Rodríguez; Wendy V Jaraba-Álvarez; Isaura Torres; Miguel A Medina-Rivas; Augusto Valderrama-Aguirre; I King Jordan; Juan Esteban Gallo
Journal:  Front Genet       Date:  2019-03-22       Impact factor: 4.599

10.  Population structure and pharmacogenomic risk stratification in the United States.

Authors:  Shashwat Deepali Nagar; Andrew B Conley; I King Jordan
Journal:  BMC Biol       Date:  2020-10-13       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.